These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23792527)

  • 21. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
    Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
    Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Sundaram V; Jalan R; Wu T; Volk ML; Asrani SK; Klein AS; Wong RJ
    Gastroenterology; 2019 Apr; 156(5):1381-1391.e3. PubMed ID: 30576643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of MELD score in country with low organ donation.
    Limsrichamrern S; Mahawithitwong P; Sirivatanauksorn Y; Mitmanochai P
    J Med Assoc Thai; 2013 Aug; 96(8):924-8. PubMed ID: 23991598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who is too healthy and who is too sick for liver transplantation: external validation of prognostic scores and survival-benefit estimation.
    Åberg F; Nordin A; Mäkisalo H; Isoniemi H
    Scand J Gastroenterol; 2015; 50(9):1144-51. PubMed ID: 25865580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.
    Suzuki H; Bartlett AS; Muiesan P; Jassem W; Rela M; Heaton N
    Transplant Proc; 2012 Mar; 44(2):384-8. PubMed ID: 22410023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match.
    Avolio AW; Agnes S; Gasbarrini A; Nure E; Siciliano M; Castagneto M
    Transplant Proc; 2006 May; 38(4):1059-62. PubMed ID: 16757263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for long-term mortality in a large cohort of patients wait-listed for liver transplantation in Brazil.
    Basto ST; Villela-Nogueira CA; Tura BR; Coelho HS; Ribeiro J; Fernandes ES; Schmal AF; Victor L; Luiz RR; Perez RM
    Liver Transpl; 2011 Sep; 17(9):1013-20. PubMed ID: 21604358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictors of mortality among liver transplant candidates].
    Erez D; Ben Ari Z; Michowitz R; Mor E
    Harefuah; 2011 Jan; 150(1):16-20, 70, 69. PubMed ID: 21449150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
    Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.